NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Across Minneapolis, Target employees are marching and volunteering amid the immigration crackdown, while pressing company leadership to do moreRead More